![]() |
Name |
Fumiquinazoline A
|
Molecular Formula | C24H23N5O4 | |
IUPAC Name* |
(1S,4R)-4-[[(2S,3aS,4S)-4-hydroxy-2-methyl-1-oxo-3,3a-dihydro-2H-imidazo[1,2-a]indol-4-yl]methyl]-1-methyl-2,4-dihydro-1H-pyrazino[2,1-b]quinazoline-3,6-dione
|
|
SMILES |
C[C@H]1C2=NC3=CC=CC=C3C(=O)N2[C@@H](C(=O)N1)C[C@]4([C@H]5N[C@H](C(=O)N5C6=CC=CC=C64)C)O
|
|
InChI |
InChI=1S/C24H23N5O4/c1-12-19-27-16-9-5-3-7-14(16)22(32)28(19)18(20(30)25-12)11-24(33)15-8-4-6-10-17(15)29-21(31)13(2)26-23(24)29/h3-10,12-13,18,23,26,33H,11H2,1-2H3,(H,25,30)/t12-,13-,18+,23-,24-/m0/s1
|
|
InChIKey |
DQQCCKFZJNINST-VCPZKGNQSA-N
|
|
Synonyms |
FUMIQUINAZOLINE A; CHEBI:64546; 140715-85-1; (1S,4R)-4-[[(2S,3aS,4S)-4-hydroxy-2-methyl-1-oxo-3,3a-dihydro-2H-imidazo[1,2-a]indol-4-yl]methyl]-1-methyl-2,4-dihydro-1H-pyrazino[2,1-b]quinazoline-3,6-dione; (1S,4R)-4-{[(2S,9S,9aS)-9-hydroxy-2-methyl-3-oxo-2,3,9,9a-tetrahydro-1H-imidazo[1,2-a]indol-9-yl]methyl}-1-methyl-2H-pyrazino[2,1-b]quinazoline-3,6(1H,4H)-dione; CHEMBL2229120; SCHEMBL12931221; DTXSID801017927; ZINC15219741; NCGC00380614-01; C22147; Q27133341; FQA; NCGC00380614-01_C24H23N5O4_2H-Pyrazino[2,1-b]quinazoline-3,6(1H,4H)-dione, 1-methyl-4-[[(2S,9S,9aS)-2,3,9,9a-tetrahydro-9-hydroxy-2-methyl-3-oxo-1H-imidazo[1,2-a]indol-9-yl]methyl]-, (1S,4R)-
|
|
CAS | 140715-85-1 | |
PubChem CID | 11247802 | |
ChEMBL ID | CHEMBL2229120 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 445.5 | ALogp: | 0.6 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 114.0 | Aromatic Rings: | 6 |
Heavy Atoms: | 33 | QED Weighted: | 0.551 |
Caco-2 Permeability: | -5.602 | MDCK Permeability: | 0.00001470 |
Pgp-inhibitor: | 0.185 | Pgp-substrate: | 0.567 |
Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.017 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.279 | Plasma Protein Binding (PPB): | 63.26% |
Volume Distribution (VD): | 1.892 | Fu: | 28.75% |
CYP1A2-inhibitor: | 0.03 | CYP1A2-substrate: | 0.106 |
CYP2C19-inhibitor: | 0.038 | CYP2C19-substrate: | 0.345 |
CYP2C9-inhibitor: | 0.059 | CYP2C9-substrate: | 0.117 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.168 |
CYP3A4-inhibitor: | 0.192 | CYP3A4-substrate: | 0.916 |
Clearance (CL): | 2.086 | Half-life (T1/2): | 0.138 |
hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.992 |
Drug-inuced Liver Injury (DILI): | 0.983 | AMES Toxicity: | 0.038 |
Rat Oral Acute Toxicity: | 0.076 | Maximum Recommended Daily Dose: | 0.955 |
Skin Sensitization: | 0.52 | Carcinogencity: | 0.57 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.937 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002409 | ![]() |
0.774 | D0G9YH | ![]() |
0.291 | ||
ENC003666 | ![]() |
0.582 | D0V9WF | ![]() |
0.288 | ||
ENC004162 | ![]() |
0.579 | D02TJS | ![]() |
0.281 | ||
ENC001979 | ![]() |
0.569 | D04VKS | ![]() |
0.275 | ||
ENC005478 | ![]() |
0.569 | D0QV5T | ![]() |
0.275 | ||
ENC000977 | ![]() |
0.543 | D0E3OF | ![]() |
0.274 | ||
ENC001948 | ![]() |
0.537 | D0B1FE | ![]() |
0.273 | ||
ENC003203 | ![]() |
0.530 | D07VHR | ![]() |
0.272 | ||
ENC003272 | ![]() |
0.500 | D01TSI | ![]() |
0.271 | ||
ENC004267 | ![]() |
0.478 | D08FTG | ![]() |
0.268 |